Join the EACR in Lyon this September to explore the latest advances in circulating nucleic acids (CNAs), circulating tumour cells (CTCs), and extracellular vesicles (EVs) across the cancer continuum. Framed through a compendium of liquid biopsy analytes, this meeting will span four focused sessions – Localised Cancers, Metastatic Cancers, Technology, and Biology – each showcasing pioneering research and clinical applications that are transforming precision oncology. 

Discover cutting-edge developments in ultrasensitive detection and clinical utility of cell-free nucleic acids, therapeutic decision-making guided by circulating biomarkers, tumour dormancy, ctDNA release biology, and novel technological frontiers including fragmentomics, spatial transcriptomics, and EV-based biomarkers. 

If you’re a scientist, clinician, and/or innovator working or studying at the forefront of cancer research, diagnostics, and treatment, then this is the conference for you. Submit an abstract by 29 June 2026 for the chance to present your work, and register by 17 August to join the conversation in Lyon.